taper_shift
TL3 Regular · Nijmegen, NL
Journal club attendee. Interested in trial design more than in trial conclusions.
Joined 10 August 2024 · last posted 10d · groups: journal-club
111 posts, newest first. Showing up to 150.
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #40 · Access › Insurance & coverage · 18 Jul 2026 · 9 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Restarting after a long gap: what the labelling implies Replied, post #28 · Practice › Dosing & titration · 16 Jul 2026 · 1 like Worth separating two things that post #24 runs together. Splitting a weekly dose in two: the pharmacokinetic argument against is that you want the benefit of long…
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #105 · Evidence › Journal club · 14 Jul 2026 · 26 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Prior authorisation: what the criteria usually require — a second dataset Replied, post #25 · Access › Insurance & coverage · 13 Jul 2026 · 11 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Insurance and replacement policies, compared Replied, post #85 · Sourcing › Logistics · 13 Jul 2026 · 24 likes Import restrictions by jurisdiction: what is legal to import for personal use varies enormously by country. Some jurisdictions are quite permissive; others are not.…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #70 · Analytics › Home & field testing · 11 Jul 2026 · 2 likes This follows post #67 rather than contradicting it. Why third-party testing is stronger: a home test run by the person who made the compound is a self-selected result.…
-
Follow-up: Signs of dehydration worth acting on Replied, post #18 · Safety › Adverse events · 8 Jul 2026 · 15 likes post #17 answers the question as asked. The question underneath it is different. Acute kidney injury: rare but reported. Symptoms (decreased urine output, creatinine…
-
Second pass at: The storage lookup and where its data comes from Replied, post #39 · Data & Tools › Calculators · 1 Jul 2026 · 4 likes I read post #37 twice before replying, because I had assumed the opposite. Reporting bugs: if you notice a calculator giving wrong results, report it in this…
-
Second pass at: Cost versus information: making the trade-off explicitly Replied, post #14 · Analytics › Home & field testing · 1 Jul 2026 · 0 likes post #13 is right about the mechanism and I think understates the practical bit. Enzyme assays: if you have an enzyme that reacts specifically with your compound, an…
-
Reading a home test result without over-claiming Replied, post #100 · Analytics › Home & field testing · 30 Jun 2026 · 16 likes Precision of home tests: most consumer-accessible devices are not precise to the level people want ("is this 99% pure or 97% pure"). They give a yes/no or a rough…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #18 · Nutrition & Training › Protein & intake · 29 Jun 2026 · 13 likes I read post #16 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Follow-up: Prior authorisation: what the criteria usually require Replied, post #38 · Access › Insurance & coverage · 25 Jun 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Revisiting: Protein density versus volume when you cannot eat much Replied, post #8 · Nutrition & Training › Protein & intake · 25 Jun 2026 · 4 likes Picking up post #5: that is the part I would want checked first. Protein targets during weight loss: the standard recommendation is 1.6 to 2.2 grams per kilogram of…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #69 · Practice › Reconstitution · 3 Jun 2026 · 7 likes On post #65 — agreed on the reasoning, with one qualification. The decimal-point error: computing 5 mg / 2 mL as 0.25 mg/mL instead of 2.5 mg/mL is the most common…
-
Pooling trials with different estimands Replied, post #3 · marked as the solution · Evidence › Meta-analyses · 1 Jun 2026 · 7 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Five questions in one post gets you one answer — how to split them Replied, post #90 · Start Here › How to Ask · 25 May 2026 · 0 likes I read post #88 twice before replying, because I had assumed the opposite. Chromatogram questions: describe the method first. Column type, gradient, wavelength,…
-
Documenting a supplier's response to a discrepancy Replied, post #2 · Sourcing › Vendor reports · 23 May 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Follow-up: Search filters: what is missing Replied, post #99 · Meta › Site feedback · 11 May 2026 · 5 likes On post #95 — agreed on the reasoning, with one qualification. Guideline clarity: if the guidelines are unclear or seem to be applied inconsistently, post the specific…
-
A 40-week log with the measurement method stated — what changed since Replied, post #3 · Outcomes › Progress reports · 5 May 2026 · 29 likes Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs without breathlessness) are measurements that…
-
What a good consultation looks like from the other side Replied, post #35 · Clinical › Prescriber conversations · 26 Apr 2026 · 5 likes On post #31 — agreed on the reasoning, with one qualification. Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #114 · Pharmacology › Pharmacokinetics · 22 Apr 2026 · 1 like Worth separating two things that post #110 runs together. Volume of distribution: the theoretical volume the drug distributes into. For albumin-binding compounds,…
-
How to ask about something you suspect is a bad idea Replied, post #78 · Start Here › How to Ask · 18 Apr 2026 · 26 likes Avoid "any advice?" at the end. It is so generic that people do not know which part of the post it refers to. Pick the specific part and ask that specific question…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria Replied, post #8 · Analytics › Method validation · 18 Apr 2026 · 0 likes Accuracy: the method measures what you intend to measure. For purity methods, this is tested by spike-and-recover experiments: add a known amount of impurity to a…
-
Conditions that change the calculus rather than forbidding it Replied, post #9 · Safety › Contraindications · 16 Apr 2026 · 19 likes Severe hepatic impairment: less is known than for kidney disease. Extreme caution or contraindication depending on the specific degree of impairment.
-
Bug report: the reconstitution calculator and a rounding edge case Replied, post #58 · Data & Tools › Calculators · 9 Apr 2026 · 8 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Follow-up: State-level differences that actually matter Replied, post #89 · Regional › North America · 8 Apr 2026 · 0 likes United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated. Compounds are prescription-only. Coverage is decided by individual plans,…
-
Spike-and-recover accuracy for a peptide assay Replied, post #11 · Analytics › Method validation · 7 Apr 2026 · 30 likes Coming back to post #9, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #71 · Clinical › Special populations · 13 Mar 2026 · 0 likes Older adults: sarcopenia risk is higher, polypharmacy is common, and the clinical trials did not enroll many people over 75. Extrapolating to very old people is…
-
Reused chromatograms across lots: how to spot it Replied, post #26 · Analytics › COA interpretation · 12 Mar 2026 · 10 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #141 · Analytics › COA interpretation · 27 Feb 2026 · 18 likes When method identifiers are missing: "reversed-phase HPLC" is less specific than "reversed-phase HPLC at 214 nm on a C18 column with a 10 to 40% acetonitrile gradient…
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #100 · Access › Pricing · 26 Feb 2026 · 14 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #72 · Evidence › Study critique · 21 Feb 2026 · 0 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #114 · Practice › Interactions · 18 Feb 2026 · 21 likes On post #110 — agreed on the reasoning, with one qualification. Oral medications versus time: if you take an oral medication 30 minutes before semaglutide (which slows…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #43 · Practice › Side effects · 6 Feb 2026 · 5 likes Fatigue: commonly reported, frequently multifactorial. It is worth asking whether other factors have changed (sleep, training volume, diet adequacy, hydration) before…
-
[2026 update] What a purity-only report leaves out Replied, post #13 · Sourcing › Independent verification · 31 Jan 2026 · 17 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Non-inferiority margins: how they are chosen and how they are abused Replied, post #41 · Evidence › Trials · 30 Jan 2026 · 15 likes Population narrowness: most trials in this class enrolled fairly specific groups. Baseline body mass index ranges, exclusion of renal disease, exclusion of certain…
-
Non-inferiority margins: how they are chosen and how they are abused — a second dataset Replied, post #13 · Evidence › Trials · 23 Jan 2026 · 8 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Guidelines revision: what changed and why — does this still hold? Replied, post #3 · Meta › Announcements · 10 Jan 2026 · 31 likes When announcements are made: major policy changes, technical changes affecting site function, planned downtime, and changes to guidelines all get announced here.
-
Moderation log format change Replied, post #20 · Meta › Announcements · 9 Jan 2026 · 0 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
Angle of injection and whether 90 degrees is always right Replied, post #75 · Practice › Administration · 1 Jan 2026 · 3 likes A genuinely late dose: the labelling generally says that if the next dose is more than a couple of days away, take it as soon as you notice. If the next dose is close,…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #49 · Compounds › Semaglutide · 27 Dec 2025 · 3 likes Worth separating two things that post #45 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Tracking a preprint to publication: a worked example Replied, post #42 · Evidence › Preprints · 4 Dec 2025 · 0 likes This follows post #39 rather than contradicting it. Always label it as a preprint in any discussion. A preprint is not a published trial and it is not settled…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #15 · Safety › Contraindications · 1 Dec 2025 · 3 likes Diabetic retinopathy complications: a signal for this was noted in SUSTAIN 6. Current evidence is mixed. The risk is not zero and some caution is appropriate in people…
-
The headache that turns out to be dehydration Replied, post #72 · Nutrition & Training › Hydration & electrolytes · 27 Nov 2025 · 23 likes Fluid intake: baseline needs increase with gastrointestinal effects and exercise. Thirst is not a reliable guide during appetite suppression. Drinking regularly (not…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #45 · Compounds › Other compounds · 24 Nov 2025 · 2 likes This follows post #42 rather than contradicting it. Reading a supplier's product description as a marketing document: that is exactly what it is. The hyperbole, the…
-
Documentation that materially improves an appeal's chances Replied, post #63 · Access › Insurance & coverage · 14 Nov 2025 · 2 likes Worth separating two things that post #59 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Second pass at: The mass-error checker and its intended scope Replied, post #62 · Data & Tools › Calculators · 13 Nov 2025 · 6 likes Coming back to post #60, because the follow-up matters more than the original answer. Reporting bugs: if you notice a calculator giving wrong results, report it in this…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #41 · Compounds › Oral incretins · 12 Nov 2025 · 9 likes The SOUL trial: cardiovascular outcomes trial for oral semaglutide in people with type 2 diabetes and cardiovascular disease or chronic kidney disease. It demonstrates…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #28 · Analytics › Method validation · 31 Oct 2025 · 29 likes Stability-indicating method: one that can separate a compound from its degradation products. Critical for assay methods that claim to measure actual degradation (as…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #40 · Clinical › Special populations · 24 Oct 2025 · 0 likes On post #36 — agreed on the reasoning, with one qualification. Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes…
-
Payment mechanics and the recovery options that do not exist Replied, post #90 · Sourcing › Payments · 23 Oct 2025 · 2 likes No payment facilitation: this site does not handle payments and does not connect buyers and sellers for the purpose of payment. We discuss logistics and documentation…
-
Thyroid function tests during substantial weight change Replied, post #98 · Clinical › Bloodwork · 16 Oct 2025 · 0 likes post #97 answers the question as asked. The question underneath it is different. Biological variation: the person-to-person variation in a biomarker for a healthy…
-
Why "any advice?" is the least effective ending for a post — the long version Replied, post #70 · Start Here › How to Ask · 16 Oct 2025 · 32 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Dizziness on standing and the electrolyte explanation — does this still hold? Replied, post #8 · marked as the solution · Practice › Side effects · 16 Oct 2025 · 7 likes Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some people. Site rotation, avoiding reinjection into the same area…
-
Reading a supplier's product description as a marketing document Replied, post #82 · Compounds › Other compounds · 10 Oct 2025 · 13 likes I read post #80 twice before replying, because I had assumed the opposite. This subcategory exists because some people will research compounds outside the main groups…
-
Managing an unplanned gap in supply — what changed since Replied, post #82 · Access › Shortages · 8 Oct 2025 · 3 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
The most useful thing you learned here that was not the answer you came for — a second… Replied, post #64 · Lounge › Off topic · 29 Sep 2025 · 15 likes Newer drugs and mechanisms: when a new drug launches or a new mechanism is discovered, the Lounge is a place to discuss the news and speculate before hard data exists.
-
Sleep quality changes during weight loss — what changed since Replied, post #8 · Wellbeing › Sleep · 24 Sep 2025 · 1 like This follows post #5 rather than contradicting it. When sleep problems need attention: if sleep does not improve as weight loss continues or if it worsens, discussing…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #72 · Practice › Administration · 21 Sep 2025 · 0 likes I read post #70 twice before replying, because I had assumed the opposite. Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from…
-
Reverse causation in a cohort study of weight and outcome — a second dataset Replied, post #17 · Evidence › Study critique · 12 Sep 2025 · 5 likes This follows post #14 rather than contradicting it. Confounding: in observational data, is there a third variable that explains the apparent association? In randomised…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #106 · Data & Tools › Datasets · 10 Sep 2025 · 1 like Coming back to post #104, because the follow-up matters more than the original answer. Privacy: if contributing data, only share data you are comfortable making…
-
Coming back to: Resolution and tailing factor: real acceptance criteria Replied, post #63 · Analytics › HPLC & UHPLC · 8 Sep 2025 · 15 likes post #62 is right about the mechanism and I think understates the practical bit. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #10 · Analytics › Method validation · 22 Aug 2025 · 0 likes Specificity: the method can distinguish the intended compound from related impurities and degradation products. Tested by comparing results on pure compounds, mixtures…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #107 · Practice › Reconstitution · 17 Aug 2025 · 0 likes Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin syringe, you need a concentration high enough that 0.25 mg fits on the scale. A 0.25…
-
Coming back to: What happens when a maintainer goes quiet Replied, post #6 · Documentation › Doc review · 2 Aug 2025 · 8 likes I read post #4 twice before replying, because I had assumed the opposite. Revision disputes: if you disagree with an edit a maintainer made to a page, discuss it here.…
-
Asking about a compound your prescriber has not heard of Replied, post #80 · Clinical › Prescriber conversations · 30 Jun 2025 · 3 likes Coming back to post #78, because the follow-up matters more than the original answer. Preparing for an appointment: bring recent bloodwork, a list of current…
-
Area percent versus weight percent: the confusion that causes most arguments — what… Replied, post #18 · Analytics › HPLC & UHPLC · 24 Jun 2025 · 10 likes Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run resolves more impurities and gives a higher purity…
-
Random versus fixed effects: choosing rather than defaulting Replied, post #8 · Evidence › Meta-analyses · 21 Jun 2025 · 17 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #103 · Nutrition & Training › Protein & intake · 16 Jun 2025 · 0 likes Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be as satiating as solid food. Using both together can help.
-
Follow-up: Tracking intake honestly when appetite is absent Replied, post #43 · Nutrition & Training › Protein & intake · 8 Jun 2025 · 32 likes Fibre: adequate fibre intake supports fullness and gut motility, both of which matter during the gastrointestinal effects of these compounds. High fibre on top of…
-
A side-effect grading scheme this community uses, and its limits Started this topic · Practice › Side effects · 4 Jun 2025 · 1 like Posting this under the heading it deserves: A side-effect grading scheme this community uses, and its limits Everything below is what sits behind that. Reporting…
-
DXA precision and the least significant change for lean mass — the long version Replied, post #60 · Outcomes › Body composition · 18 May 2025 · 0 likes Precision versus accuracy: the precision you need depends on what question you are answering. "Am I losing fat?" requires less precision than "Is my lean mass…
-
Reading a rodent study on a secretagogue without over-extrapolating Replied, post #7 · Compounds › Secretagogues & GH axis · 16 May 2025 · 0 likes This follows post #4 rather than contradicting it. CJC-1295 with and without DAC: the version with a drug affinity complex binds albumin covalently and persists for…
-
Coming back to: Sample size calculations, read backwards from the published number Replied, post #23 · Evidence › Trials · 9 May 2025 · 4 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #148 · Sourcing › Regulatory · 9 May 2025 · 0 likes Picking up post #145: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the…
-
Bleeding at the injection site: normal, and what to do about it — does this still hold? Replied, post #25 · Practice › Administration · 6 May 2025 · 0 likes Injecting into an area that has become firm: lipohypertrophy — thickened fatty tissue from repeated injection in one area — changes local tissue absorption. Avoid…
-
Fibre intake when total intake falls, and the constipation link Replied, post #57 · Nutrition & Training › Protein & intake · 22 Apr 2025 · 22 likes Eating anything at all: on substantial appetite suppression, eating enough total calories to maintain lean mass is the priority. Protein comes second to total intake.
-
Charge states for a 4 kDa peptide, worked through Replied, post #122 · Analytics › Mass spectrometry · 16 Mar 2025 · 5 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #28 · Sourcing › Vendor reports · 15 Mar 2025 · 8 likes post #27 answers the question as asked. The question underneath it is different. Date the report: when the analysis was done matters. Material can degrade in storage. A…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #31 · Clinical › Comorbidities · 11 Mar 2025 · 0 likes I read post #29 twice before replying, because I had assumed the opposite. Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in…
-
Consistent declarations and why they matter more than clever ones Replied, post #160 · Sourcing › Logistics · 10 Mar 2025 · 1 like post #159 answers the question as asked. The question underneath it is different. Declaring contents accurately: declaring accurately reduces intervention risk. A…
-
Charge states for a 4 kDa peptide, worked through Replied, post #42 · Analytics › Mass spectrometry · 7 Mar 2025 · 10 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Obstructive sleep apnoea and a hard endpoint in this class Replied, post #26 · Clinical › Comorbidities · 4 Mar 2025 · 32 likes Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not…
-
Coverage for the indication versus for the drug — a second dataset Started this topic · Access › Insurance & coverage · 3 Mar 2025 · 12 likes On the subject in the title: Coverage for the indication versus for the drug — a second dataset Working notes rather than a conclusion. A coverage question with the…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #27 · Compounds › Other compounds · 2 Mar 2025 · 1 like This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #61 · Compounds › Semaglutide · 12 Feb 2025 · 0 likes post #60 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Reporting a good result: why nobody bothers and why they should — one year on Replied, post #25 · Sourcing › Vendor reports · 22 Jan 2025 · 0 likes Blind submission is worth the effort: have someone else relabel the sample so neither you nor the laboratory knows which supplier it came from until the result is back.…
-
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #6 · Access › International · 20 Jan 2025 · 3 likes Customs and import outcomes: different routes have different seizure rates. Some countries are stricter on peptide imports than others. History on a route is more…
-
What changed in 2026, by region Replied, post #83 · Access › International · 17 Jan 2025 · 8 likes Picking up post #80: that is the part I would want checked first. Travel with medication: carrying a compound across borders is complicated by legal status. Documenting…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #12 · Compounds › Other compounds · 12 Jan 2025 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Journal club: STEP 4 and what a withdrawal design can prove — one year on Replied, post #23 · Evidence › Journal club · 10 Jan 2025 · 0 likes FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney disease. Stopped early for efficacy. Component-by-component analysis is…
-
[2026 update] New subcategory: rationale and scope Replied, post #130 · Meta › Announcements · 8 Jan 2025 · 0 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #9 · Practice › Reconstitution · 7 Jan 2025 · 9 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #139 · Practice › Dosing & titration · 1 Jan 2025 · 14 likes On post #135 — agreed on the reasoning, with one qualification. Holding a dose indefinitely: the trials did not study indefinite holding at a non-maximum dose. The…
-
[2026 update] Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #78 · Evidence › Journal club · 1 Jan 2025 · 1 like Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #43 · Compounds › Semaglutide · 26 Dec 2024 · 0 likes The STEP programme populations were selected: enrollment criteria required baseline body mass index over 30, no recent blood pressure crisis, no recent retinopathy, no…
-
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #9 · Compounds › Semaglutide · 18 Dec 2024 · 0 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Coming back to: When to suspect the method rather than the sample Replied, post #81 · Analytics › Method validation · 16 Dec 2024 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: When to suspect the method rather than the sample Replied, post #64 · Analytics › Method validation · 12 Dec 2024 · 3 likes System suitability: injections run at the start of a batch to establish that the instrument and column are performing. Acceptance criteria typically include replicate…
-
Body image changing more slowly than the body Replied, post #6 · Wellbeing › Mental health · 10 Dec 2024 · 8 likes Identity and self-image: for some people, weight and body size are central to identity. Large change to body size can affect identity. This is not pathological; it is…
-
Meeting a protein target on a suppressed appetite — does this still hold? Replied, post #45 · Nutrition & Training › Protein & intake · 8 Dec 2024 · 0 likes Picking up post #42: that is the part I would want checked first. Liquid versus solid: protein in liquid form (shakes) is easier to consume in volume but might not be…
-
A promotion I argued against, and why I lost Replied, post #19 · Documentation › Doc review · 2 Dec 2024 · 25 likes Fact-checking: if you see a factual claim in a maintained page that you have evidence contradicts, post the evidence here. The maintainer will review and correct if you…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #80 · Analytics › Method validation · 25 Nov 2024 · 22 likes Forced degradation studies: deliberately stress the material with acid, base, oxidant, heat, light to generate degradation products and demonstrate that the method can…
-
Time to steady state after a dose increase Replied, post #59 · Pharmacology › Pharmacokinetics · 4 Nov 2024 · 33 likes On post #55 — agreed on the reasoning, with one qualification. Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The…
-
US compounding rules and how they changed Replied, post #30 · Regional › North America · 18 Oct 2024 · 11 likes Picking up post #27: that is the part I would want checked first. Indigenous healthcare systems: different indigenous healthcare systems have different medication…
-
Second pass at: Food noise reducing and the disorientation that can follow Replied, post #33 · Wellbeing › Mental health · 15 Oct 2024 · 0 likes Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #24 · Practice › Administration · 12 Sep 2024 · 0 likes Picking up post #21: that is the part I would want checked first. Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #14 · Sourcing › Independent verification · 24 Aug 2024 · 8 likes post #13 is right about the mechanism and I think understates the practical bit. VendorInvestigate: documentation and supplier-practice review. Reviews paperwork rather…
-
The C-cell question: rodent findings and their human context — what changed since Replied, post #13 · Compounds › Semaglutide · 19 Aug 2024 · 0 likes post #12 answers the question as asked. The question underneath it is different. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that…
-
How to ask for a dose change without antagonising anyone Replied, post #10 · Clinical › Prescriber conversations · 31 Jul 2024 · 33 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
What happens when a maintainer goes quiet Replied, post #6 · Documentation › Doc review · 20 Jun 2024 · 31 likes Interdependencies: if updating one page requires updating related pages, posting that connection here helps the maintainers see the scope of work.